What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 6 minute read Technology News Investors eye dilution risk after Syntheia Corp issues 4.9m shares to settle debt Find out how Syntheia Corp is resolving over US$590K in debt via share issuance and what it means for AI-sector investors. byPallavi MadhirajuNovember 15, 2025